Entry into a Material Definitive Agreement

Vivakor, Inc. (VIVK) - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K covers events occurring on October 16, 2025, with the offering closing on October 17, 2025. Vivakor, Inc., a Nevada corporation listed on the Nasdaq Capital Market, announced the completion of a registered direct offering to raise capital for working capital and general corporate purposes.

Key Financial Metrics and Transaction Details

The filing details a capital raise transaction rather than periodic financial performance metrics (revenue, profit, or cash flow). Key transaction figures include:

  • Aggregate Gross Proceeds: Approximately $5 million.
  • Common Stock Issued: 8,417,645 shares at an offering price of $0.2164 per share.
  • Pre-Funded Warrants Issued: 14,689,851 warrants at an offering price of $0.2154 per warrant.
  • Placement Agent Fees: 7% cash fee plus 1% for non-accountable expenses, plus reimbursement of certain expenses and legal fees.
  • Warrant Terms: Immediately exercisable at $0.001 per share; subject to 4.99% (or 9.99% upon election) beneficial ownership limitations.

Material Changes

The primary material change is the dilution of existing shareholders due to the issuance of new common stock and pre-funded warrants. The filing does not provide comparative financial data (e.g., year-over-year revenue or profit changes) as this is a transactional report, not a periodic earnings filing.

Outlook, Risks, and Management Commentary

Use of Proceeds: Management intends to utilize net proceeds for working capital and general corporate purposes.
Risks and Contingencies: The transaction involves immediate dilution. The pre-funded warrants include ownership limitations to prevent any single holder from exceeding specific beneficial ownership thresholds without prior election. The company is classified as an emerging growth company.

Investor Verification Checklist

  • Verify the exact number of shares outstanding post-closing to assess dilution impact.
  • Confirm the final net proceeds after deducting the 7% placement fee, 1% expense fee, and legal costs.
  • Review the "shelf" registration statement (File No. 333-269178) for any additional terms or restrictions.
  • Monitor the exercise of pre-funded warrants, as they are immediately exercisable at a nominal cost.
  • Check subsequent filings for updates on the specific allocation of the raised capital.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.